OpenAlex
PricingAboutJobs
Log inGet started
Work

Oral insulin administration and residual (β-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial

HTML

Year: 2000
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Lancet
DOI: 10.1016/s0140-6736(00)02579-4
Authors: Lucy Chaillous, Hervé Lefèvre, Charles Thivolet, Christian Boitard, Najiba Lahlou, Catherine Atlan-Gepner, Béatrice Bouhanick, Agnès Mogenet, Marc Nicolino, Jean-Claude Carel, Pierre Lecomte, Richard Maréchaud, Pierre Bougnères, Bernard Charbonnel, Pierre Saï
Institutions: Centre Hospitalier Universitaire de Nantes, Hôpital Saint-Vincent-de-Paul, Centre Hospitalier Universitaire d'Angers, Centre Hospitalier Universitaire de Tours, Centre Hospitalier Universitaire de Poitiers
Language: English

Topic: Diabetes and associated disorders
Subfield: Genetics
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: oral insulin, type 1 diabetes, residual beta-cell function, C-peptide, beta-cell autoantibodies, glutamic acid decarboxylase antibodies, insulin autoantibodies, beta cell destruction, recent-onset diabetes, subcutaneous insulin therapy
SDG: Good health and well-being

Open Access status: closed

Funders: Eli Lilly and Company, Fondation pour la Recherche Médicale, Fondation de France
OpenAlex ID: W2153644370
FWCI: 7.956
Cites: 30
Cited by: 271
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms